ANBT
WVE icon

American National Bank & Trust’s Wave Life Sciences WVE Stock Holding History

American National Bank & Trust’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$366 – 772
2025
Q3 		$366 Hold
50
– – ﹤0.01% 629
2025
Q2 		$325 Buy
+50
New +$330 ﹤0.01% 637

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

American National Bank & Trust's WVE Position: Q4 2025 in Review

American National Bank & Trust sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 50 shares — an estimated $366 sold.

American National Bank & Trust first reported a position in WVE in Q2 2025 and held it in 2 quarters. The position peaked at $366 in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • American National Bank & Trust reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • American National Bank & Trust sold 50 Wave Life Sciences shares in Q4 2025, an estimated $366.
  • American National Bank & Trust first reported a position in Wave Life Sciences in Q2 2025 and held it in 2 quarters.
  • American National Bank & Trust's Wave Life Sciences position peaked at $366 in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on American National Bank & Trust's 13F filing for Q4 2025, filed 20 Jan 2026.